Symbols

INCY

Incyte·NASDAQ

--(--)

INCY Profile

Incyte Corporation

A global biopharmaceutical company that develops small molecule drugs to treat cancer and inflammatory diseases

Industry

Biological Technology

Established Date

Listing Date

11/04/1993

Exchange

NASDAQ Stock Exchange

Full-time Employees

2,844

Fiscal Year Ends

12-31

Website

www.incyte.com

Security Type

Common stock

Office address

1801 Augustine Cut-Off, Wilmington, DE 19803

Business

Introduction

Incyte Corporation was incorporated in Delaware in 1991. The Company is a global biopharmaceutical company engaged in the discovery, development and commercialization of proprietary therapies. Its research and commercial efforts focus on three therapeutic areas: hematology, oncology, inflammation and autoimmunity.